# Cognition Therapeutics Inc: filings

CGTX · Nasdaq · CIK 1455365 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cgtx.md) · [Financials](/companies/cgtx/financials.md) · [Filings](/companies/cgtx/filings.md) · [Insiders](/companies/cgtx/insiders.md)

## Reports and events: 108 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 91, 8-K 72, 3 16, 10-Q 15, CORRESP 11, 4/A 8, D 8, 424B5 7, UPLOAD 7, S-8 6, 10-K 5, DEF 14A 5, DEFA14A 5, EFFECT 5, ARS 4, D/A 4, S-1/A 4, 424B4 3, S-3 3, SC 13D/A 3, 3/A 2, DRS 2, S-1 2, SC 13G 2, SC 13G/A 2, 8-A12B 1, CERT 1, DRS/A 1, DRSLTR 1, REGDEX 1, S-1MEF 1, SC 13D 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 10:06 ET | [8-K](/filings/0001104659-26-117948.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-117948 |
| 2026-08-07 | 11:30 ET | [10-Q](/filings/0001104659-26-092362.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092362 |
| 2026-08-06 | 20:18 ET | [8-K](/filings/0001104659-26-092037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-092037 |
| 2026-06-24 | 11:39 ET | [8-K](/filings/0001104659-26-077060.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-077060 |
| 2026-06-18 | 12:05 ET | [8-K](/filings/0001104659-26-075442.md) | 5.07 Shareholder vote results | 0001104659-26-075442 |
| 2026-06-04 | 12:00 ET | [8-K](/filings/0001104659-26-070345.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-070345 |
| 2026-05-21 | 11:34 ET | [8-K](/filings/0001104659-26-064863.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-064863 |
| 2026-05-08 | 11:30 ET | [10-Q](/filings/0001104659-26-057545.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057545 |
| 2026-05-07 | 20:24 ET | [8-K](/filings/0001104659-26-057186.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-057186 |
| 2026-04-27 | 20:05 ET | [DEF 14A](/filings/0001104659-26-049427.md) | Proxy statement, period 2026-06-17 | 0001104659-26-049427 |
| 2026-03-26 | 11:40 ET | [10-K](/filings/0001104659-26-034880.md) | Annual report, period 2025-12-31 | 0001104659-26-034880 |
| 2026-03-26 | 11:36 ET | [8-K](/filings/0001104659-26-034876.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-034876 |
| 2026-03-02 | 12:35 ET | [8-K](/filings/0001104659-26-021904.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-021904 |
| 2026-01-27 | 12:37 ET | [8-K](/filings/0001104659-26-006813.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-006813 |
| 2025-12-18 | 21:20 ET | [8-K](/filings/0001104659-25-122555.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001104659-25-122555 |
| 2025-11-06 | 12:46 ET | [10-Q](/filings/0001104659-25-107402.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107402 |
| 2025-11-06 | 12:34 ET | [8-K](/filings/0001104659-25-107390.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107390 |
| 2025-09-23 | 01:58 ET | [SCHEDULE 13D/A](/filings/0001104659-25-092675.md) | Ownership report, active investor, amended | 0001104659-25-092675 |
| 2025-09-15 | 11:00 ET | [8-K](/filings/0001104659-25-089737.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-089737 |
| 2025-08-28 | 21:10 ET | [8-K](/filings/0001104659-25-084845.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-084845 |
| 2025-08-26 | 20:01 ET | [8-K](/filings/0001104659-25-083059.md) | 8.01 Other events | 0001104659-25-083059 |
| 2025-08-07 | 21:16 ET | [8-K](/filings/0001104659-25-075268.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-075268 |
| 2025-08-07 | 20:17 ET | [10-Q](/filings/0001558370-25-010771.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010771 |
| 2025-06-20 | 20:01 ET | [8-K](/filings/0001104659-25-061142.md) | 5.07 Shareholder vote results | 0001104659-25-061142 |
| 2025-06-03 | 11:39 ET | [8-K](/filings/0001104659-25-055717.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-055717 |
| 2025-06-02 | 10:01 ET | [8-K](/filings/0001104659-25-055089.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-055089 |
| 2025-05-08 | 11:35 ET | [8-K](/filings/0001104659-25-045886.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-045886 |
| 2025-05-07 | 11:45 ET | [10-Q](/filings/0001558370-25-006612.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006612 |
| 2025-05-07 | 11:36 ET | [8-K](/filings/0001104659-25-045324.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-045324 |
| 2025-04-28 | 20:07 ET | [DEF 14A](/filings/0001104659-25-040193.md) | Proxy statement, period 2025-06-18 | 0001104659-25-040193 |
| 2025-03-20 | 11:15 ET | [10-K](/filings/0001558370-25-003341.md) | Annual report, period 2024-12-31 | 0001558370-25-003341 |
| 2025-03-20 | 11:09 ET | [8-K](/filings/0001104659-25-025828.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-025828 |
| 2025-03-12 | 20:05 ET | [8-K](/filings/0001104659-25-022969.md) | 8.01 Other events | 0001104659-25-022969 |
| 2025-02-26 | 12:09 ET | [8-K](/filings/0001104659-25-017178.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-017178 |
| 2025-01-28 | 21:41 ET | [8-K](/filings/0001104659-25-006732.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-006732 |
| 2025-01-13 | 16:55 ET | [8-K](/filings/0001104659-25-002939.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002939 |
| 2024-12-18 | 13:00 ET | [8-K](/filings/0001104659-24-129619.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-129619 |
| 2024-11-13 | 12:45 ET | [10-Q](/filings/0001558370-24-015436.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015436 |
| 2024-11-13 | 12:37 ET | [8-K](/filings/0001104659-24-117243.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-117243 |
| 2024-10-01 | 10:02 ET | [8-K](/filings/0001104659-24-104541.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-104541 |
| 2024-09-13 | 20:01 ET | [8-K](/filings/0001104659-24-099746.md) | 3.01 Delisting notice | 0001104659-24-099746 |
| 2024-08-28 | 10:26 ET | [8-K](/filings/0001104659-24-093660.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-093660 |
| 2024-08-08 | 11:16 ET | [10-Q](/filings/0001558370-24-011464.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011464 |
| 2024-08-08 | 11:12 ET | [8-K](/filings/0001104659-24-087001.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-087001 |
| 2024-07-29 | 12:30 ET | [8-K](/filings/0001104659-24-083280.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-083280 |
| 2024-06-07 | 20:06 ET | [8-K](/filings/0001104659-24-069635.md) | 5.07 Shareholder vote results | 0001104659-24-069635 |
| 2024-05-07 | 11:45 ET | [10-Q](/filings/0001558370-24-006911.md) | Quarterly report, period 2024-03-31 | 0001558370-24-006911 |
| 2024-05-07 | 11:39 ET | [8-K](/filings/0001104659-24-057711.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-057711 |
| 2024-04-26 | 20:01 ET | [DEF 14A](/filings/0001104659-24-052901.md) | Proxy statement, period 2024-06-07 | 0001104659-24-052901 |
| 2024-03-26 | 20:16 ET | [10-K](/filings/0001558370-24-003949.md) | Annual report, period 2023-12-31 | 0001558370-24-003949 |

Page 1 of 3. [Older](/companies/cgtx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.